Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Hemostats And Tissue Sealants Industry In 2025?
The hemostats and tissue sealants market has experienced robust growth in recent years. It is projected to expand from $4.07 billion in 2024 to $4.35 billion by 2025, achieving a compound annual growth rate (CAGR) of 6.9%. Historically, this growth can be attributed to an expanding geriatric population, a rising incidence of trauma and accidents, an increasing prevalence of cardiovascular disorders, greater investments in medical, and the increasing adoption of minimally invasive surgeries.
The hemostats and tissue sealants market is projected to experience substantial expansion in the coming years. This market is predicted to reach a size of $5.61 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during this period stems from several factors, including the expanded application of hemostats in ambulatory surgical centers, a rising need for biocompatible and synthetic sealants, increased capital allocation for surgical advancements and research and development, heightened understanding of blood management protocols in surgical procedures, and a general increase in healthcare spending. Key trends expected during the forecast timeframe encompass progress in synthetic polymer technology, innovative drug-delivery sealants driven by technological advancements, the incorporation of hemostatic agents into minimally invasive surgical techniques, the evolution of dual-action sealants and hemostats, and breakthroughs in bioengineered and biocompatible materials.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp
Which Industry Drivers Are Expected To Accelerate The Hemostats And Tissue Sealants Market From 2025 To 2029?
An increasing volume of surgical operations is anticipated to drive the future expansion of the hemostats and tissue sealants market. Surgical procedures are medical interventions performed by surgeons using manual and instrumental techniques to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. This rise in surgical procedures is attributed to the growing prevalence of chronic diseases, which frequently necessitate surgical intervention for effective management, treatment, or complication prevention. Hemostats and tissue sealants play a crucial role in surgical procedures by effectively managing bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, reported a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Thus, the increasing number of surgical procedures is propelling the growth of the hemostats and tissue sealants market.
What Are The Different Segment Classifications Within The Hemostats And Tissue Sealants Market?
The hemostats and tissue sealants market covered in this report is segmented –
1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types
2) By Composition: Biological Based, Synthetic Based, Combination
3) By Distribution Channel: Direct Sales, Distributors, Online Sales
4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications
5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes
Subsegments:
1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats
2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives
3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants
4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats
How Are Emerging Market Trends Shaping The Hemostats And Tissue Sealants Industry Landscape?
Leading companies in the hemostat and tissue sealants market are prioritizing the development of advanced products, such as ready-to-use absorbable collagen pads hemostat, to enhance efficiency and outcomes in surgical care. These ready-to-use absorbable collagen hemostat pads are characterized by bioactive, resorbable materials that allow for immediate application without prior preparation, facilitating quick and effective sealing of tissue and dura, as well as achieving hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat, designed for room temperature storage, at a symposium in Austria. This new room temperature Hemopatch sealing hemostat offers convenient readiness for use without requiring pre-warming, enabling rapid application during surgery. It is an innovative absorbable pad that can be directly applied during both open and minimally invasive surgeries, removing the necessity for product preparation or refrigeration. The product’s powerful adhesive qualities, extended shelf life, and fast hemostatic action aid surgeons in more efficiently managing bleeding or leakage, ultimately supporting improved surgical precision and patient recovery across diverse specialties.
Which Major Firms Are Strengthening Their Position In The Hemostats And Tissue Sealants Industry?
Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report
Which Regional Markets Are Contributing Most To The Hemostats And Tissue Sealants Industry Expansion?
North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Hemostats And Tissue Sealants Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp
Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2025, By The Business Research Company
Hemostats Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report
Hemostasis Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report
Absorbable Hemostats Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model